Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT04495894
Eligibility Criteria:
Inclusion Criteria:
* Pathology-proven or suspected stage 1 or 2 NSCLC and Stage 3 tumor stage 3, node stage 0 (T3N0) RCC, that require surgical resection as the treatment of choice
* Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
* Ability to understand and the willingness to sign an informed written consent
Exclusion Criteria:
* Individuals with pure lung ground-glass opacity (GGO) lesions or mixed GGO with \<50% solid component
* Patients undergoing pneumonectomy
* History of cancer in the 3 years prior to surgery (except for basal-cell carcinoma of the skin or cervical neoplasia).
* Contraindication for NSAIDs, including peptic ulcer disease, preoperative chronic kidney disease with estimated glomerular filtration rate (eGFR) \<45, allergies or intolerance to NSAIDs, coagulation disorder, or age \> 80 years
* Having taken an NSAID within 5 days prior to surgery
* Immunocompromised status
* Refusal or inability to understand the protocol and consent form or to receive follow-up in line with the recommendations
* Preoperative hemoglobin \< 9.0
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04495894
Study Brief:
Protocol Section:
NCT04495894